CLINICAL DECISION-MAKING CRITERIA FOR SWITCHING OR COMBINING ANTIHYPERTENSIVE MEDICATIONS: A PHYSICIAN-BASED SURVEY
Main Article Content
Keywords
Hypertension, Drug Switching, Combination Therapy, Physician Survey, Clinical Decision-Making
Abstract
Background: Hypertension remains a leading modifiable risk factor for cardiovascular morbidity and mortality. Despite the availability of various classes of antihypertensive drugs, optimal blood pressure control remains elusive in many patients, necessitating decisions about switching or combining therapies.
Objective: This study aims to assess the criteria physicians use to switch or combine antihypertensive medications in routine clinical practice.
Methods: A cross-sectional, questionnaire-based survey was conducted among 250 practicing physicians across tertiary and secondary healthcare centers in Eastern India. The questionnaire explored clinical, patient-related, and drug-related factors influencing treatment modification.
Results: Poor blood pressure control (92%), adverse drug reactions (68%), patient non-adherence (55%), and comorbidities (46%) emerged as major criteria for switching drugs. Drug combinations were preferred when monotherapy failed, especially in patients with Stage 2 hypertension (78%) or high cardiovascular risk (65%).
Conclusion: The study highlights prevalent decision-making patterns and reinforces the need for clear guidelines to optimize antihypertensive therapy adjustments in diverse clinical contexts.
References
2 Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.
3 Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control. Circulation. 2016;134(6):441–50.
4 Gupta R, Xavier D. Hypertension: The most important non-communicable disease risk factor in India. Indian Heart J. 2018;70(4):565–72.
5 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. JNC 7 report. JAMA. 2003;289(19):2560–72.
6 Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT Jr, et al. Potential US population impact of the 2017 ACC/AHA guideline. J Am Coll Cardiol. 2018;71(2):109–18.
7 Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western countries. Arch Intern Med. 2007;167(2):141–7.
8 Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190–6.
9 Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments. J Hypertens. 2008;26(1):1–13.
10 Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance. J Clin Hypertens. 2007;9(10):731–40.
11 Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004;18(2):73–8.
12 Gupta R, Gaur K, S Ram CV. Emerging trends in hypertension epidemiology in India. J Hum Hypertens. 2019;33(8):575–87.
13 Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension. JAMA. 2010;303(20):2043–50.
14 Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. PURE study: Cardiovascular disease and risk factors in 17 countries. Lancet. 2013;382(9905):586–97.
15 Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124(7):1124–40.
16 Prasad S, Kotwal A, Bharti S, Kumar R. Physician perceptions and practices regarding hypertension. Indian J Community Med. 2020;45(1):32–5.
17 Tobe SW, Stone JA, Brouwers M, Bhattacharyya O, Walker KM, Dawes M, et al. Canadian hypertension education program: Recommendations update. Can J Cardiol. 2015;31(5):549–68.
18 Jafar TH, Gandhi M, de Silva HA, Shahbaz A, Khan AQ, Kadir MM, et al. A community-based intervention for non-communicable diseases in Pakistan. N Engl J Med. 2020;382(8):717–26.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Kumari Pallavi
Senior Resident, Department of Pharmacology, Indira Gandhi Institute of Medical Sciences, Patna, India
Dr. Keshav Kumar
Senior Resident, Department of Pharmacology, Indira Gandhi Institute of Medical Sciences, Patna, India
Dr. Anshuman Chandra
Assistant Professor, Department of Pharmacology, Hi Tech Medical College and Hospital, Rourkela, Orrisa, India
Dr. Kumar Martand
Assistant Professor, Department of Anatomy, ESI-PGIMSR & ESIC Medical College and Hospital, Joka, West Bengal, India
Dr. Anita Verma
Professor & Head, Department of Pharmacology, Hi Tech Medical College and Hospital, Rourkela, Orrisa, India